Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1974 Oct;71(10):3824–3828. doi: 10.1073/pnas.71.10.3824

Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins*

Mats Hamberg 1, Jan Svensson 1, Bengt Samuelsson 1
PMCID: PMC434276  PMID: 4530264

Abstract

Methods were developed for quantitative determination of the three major metabolites of arachidonic acid in human platelets, i.e., 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE), 12L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and 8-(1-hydroxy-3-oxopropyl)-9,12L-dihydroxy-5,10-heptadecadienoic acid (PHD). Aggregation of washed platelets by thrombin was accompanied by release of 1163-2175 ng/ml of HETE, 1129-2430 ng/ml of HHT, and 998-2299 ng/ml of PHD. The amount of PGG2 (prostaglandin G2) produced as calculated from the sum of the amounts of its metabolites (HHT and PHD) was 2477-5480 ng/ml. In contrast, the amounts of PGE2 (prostaglandin E2) and PGF2α (prostaglandin F2α) released were approximately two orders of magnitude lower. In this system, the prostaglandins thus exert their biological action through the endoperoxides, which are almost exclusively metabolized to nonprostanoate structures and only to a small extent to the classical prostaglandins.

Platelets from subjects given aspirin produced less than 5% of the above mentioned amounts of HHT and PHD, whereas the production of HETE was stimulated about 3-fold. This provides additional evidence for our earlier proposal [Hamberg, M., Svensson, J., Wakabayashi, T. & Samuelsson, B. (1974) Proc. Nat. Acad. Sci. USA 71, 345-349] that the anti-aggregating effect of aspirin is through inhibition of PGG2 formation.

Keywords: platelet aggregation, prostaglandin G2, endoperoxide metabolites, quantitative determination, aspirin and indomethacin

Full text

PDF
3824

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEAUMONT J. L., WILLIE A. Influence sur l'hémostase, de l'hypertension artérielle, des antivitamines K, de l'héparine et de l'acide acétyl salicylique. Sang. 1955;26(9):880–891. [PubMed] [Google Scholar]
  2. Flower R. J., Cheung H. S., Cushman D. W. Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. Prostaglandins. 1973 Sep;4(3):325–341. doi: 10.1016/0090-6980(73)90020-8. [DOI] [PubMed] [Google Scholar]
  3. Gréen K., Granström E., Samuelsson B., Axen U. Methods for quantitative analysis of PGF2 , PGE2, 9 , 11 -dihydroxy-15-keto-prost-5-enoic acid and 9 , 11 , 15-trihydroxy-prost-5-enoic acid from body fluids using deuterated carriers and gas chromatography--mass spectrometry. Anal Biochem. 1973 Aug;54(2):434–453. doi: 10.1016/0003-2697(73)90373-4. [DOI] [PubMed] [Google Scholar]
  4. Hamberg M., Niehaus W. G., Jr, Samuelsson B. Preparation, isolation, and characterization of a derivative of malonaldehyde. Anal Biochem. 1968 Jan;22(1):145–153. doi: 10.1016/0003-2697(68)90268-6. [DOI] [PubMed] [Google Scholar]
  5. Hamberg M., Samuelsson B. Oxygenation of unsaturated fatty acids by the vesicular gland of sheep. J Biol Chem. 1967 Nov 25;242(22):5344–5354. [PubMed] [Google Scholar]
  6. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamberg M., Svensson J., Samuelsson B. Letter: Mechanism of the anti-aggregating effect of aspirin on human platelets. Lancet. 1974 Jul 27;2(7874):223–224. doi: 10.1016/s0140-6736(74)91525-6. [DOI] [PubMed] [Google Scholar]
  8. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974 Feb;71(2):345–349. doi: 10.1073/pnas.71.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kloeze J. Relationship between chemical structure and platelet-aggregation activity of prostaglandins. Biochim Biophys Acta. 1969 Oct 28;187(3):285–292. doi: 10.1016/0005-2760(69)90001-0. [DOI] [PubMed] [Google Scholar]
  10. O'Brien J. R. Effects of salicylates on human platelets. Lancet. 1968 Apr 13;1(7546):779–783. doi: 10.1016/s0140-6736(68)92228-9. [DOI] [PubMed] [Google Scholar]
  11. Quick A. J. The Minot-von Willebrand syndrome. Am J Med Sci. 1967 May;253(5):520–530. [PubMed] [Google Scholar]
  12. Shio H., Ramwell P. Effect of prostaglandin E 2 and aspirin on the secondary aggregation of human platelets. Nat New Biol. 1972 Mar 15;236(63):45–46. doi: 10.1038/newbio236045a0. [DOI] [PubMed] [Google Scholar]
  13. Smith J. B., Ingerman C., Kocsis J. J., Silver M. J. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest. 1974 May;53(5):1468–1472. doi: 10.1172/JCI107695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  15. Vargaftig B. B., Zirinis P. Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nat New Biol. 1973 Jul 25;244(134):114–116. doi: 10.1038/newbio244114a0. [DOI] [PubMed] [Google Scholar]
  16. Weiss H. J., Aledort L. M. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967 Sep 2;2(7514):495–497. doi: 10.1016/s0140-6736(67)91658-3. [DOI] [PubMed] [Google Scholar]
  17. Willis A. L. An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science. 1974 Jan 25;183(4122):325–327. doi: 10.1126/science.183.4122.325. [DOI] [PubMed] [Google Scholar]
  18. Zucker M. B., Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med. 1968 Feb;127(2):547–551. doi: 10.3181/00379727-127-32737. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES